Deletion, Correction, Integration
Intracellular measurements, remote control, labelling, novel inhibitors
Immunotherapies, gene correction, cell-based vaccines
Engineered tissues, disease modeling, drug screening in patient cells
Direct intracellular access for poorly permeable molecules
Impermeable tagged probes, proteins, and antibodies
Gene edit or modulate primary cells for assays
Intracellular delivery of DEL libraries
Proprietary Instruments and Consumables
Modifying existing high throughput workflows to be Powered by Portal™
Powered by Portal™ consumables compatible with common manufacturing equipment
Enables same-day production of autologous, therapeutic cells at the patient point-of-care/bedside